Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease.

× No keyword cloud information.

15 in total

1. Methylation and the human brain: towards a new discipline of imaging epigenetics.

Authors: Corinde E Wiers
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-09-24 Impact factor: 5.270

2. Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Authors: Y Likitjaroen; T Meindl; U Friese; M Wagner; K Buerger; H Hampel; S J Teipel
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-08-05 Impact factor: 5.270

3. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.

Authors: Liang-Hao Guo; Panagiotis Alexopoulos; Tamara Eisele; Stefan Wagenpfeil; Alexander Kurz; Robert Perneczky
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-08-30 Impact factor: 5.270

Review 4. Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors: Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2013-02-05 Impact factor: 5.270

5. Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).

Authors: Rosario de Arce Cordón; Evelin Eding; Joao Marques-Teixeira; Vihra Milanova; Elmars Rancans; Andreas Schreiner
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-08-02 Impact factor: 5.270

Review 6. Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.

Authors: J Genius; H Klafki; J Benninghoff; H Esselmann; J Wiltfang
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-09-18 Impact factor: 5.270

7. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Authors: Sönke Arlt; Ralph Buchert; Lothar Spies; Martin Eichenlaub; Jan T Lehmbeck; Holger Jahn
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-09-01 Impact factor: 5.270

8. Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.

Authors: Markus J Schwarz; Gilles J Guillemin; Stefan J Teipel; Katharina Buerger; Harald Hampel
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-11-29 Impact factor: 5.270

9. Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil.

Authors: Tomasz Gos; Johann Steiner; Hendrik Bielau; Henrik Dobrowolny; Karoline Günther; Christian Mawrin; Maciej Krzyżanowski; Roman Hauser; Ralf Brisch; Hans-Gert Bernstein; Zbigniew Jankowski; Katharina Braun; Bernhard Bogerts
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2012-04-13 Impact factor: 5.270

10. Brain perfusion asymmetry in patients with oral somatic delusions.

Authors: Yojiro Umezaki; Ayano Katagiri; Motoko Watanabe; Miho Takenoshita; Tomomi Sakuma; Emi Sako; Yusuke Sato; Akira Toriihara; Akihito Uezato; Hitoshi Shibuya; Toru Nishikawa; Haruhiko Motomura; Akira Toyofuku
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2013-01-29 Impact factor: 5.270